
Dapefy 10mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapefy 10mg Tablet
Glycemia-10 tablets (10mg) are indicated, either solely or adjunctively, in managing type 2 diabetes. They effectively regulate elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glycemia-10 may be administered with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can elevate blood sugar, potentially leading to complications like nephropathy and visual impairment. This medication forms part of a comprehensive treatment plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Diuresis may occur; adequate hydration is crucial to prevent dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals require medical consultation before use. Limit alcohol consumption, as it might exacerbate certain side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapefy 10mg Tablet
The provided text is "undefined," so no rewriting is possible.
Uses of Dapefy 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapefy 10mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dapefy 10mg Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapefy 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapefy 10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapefy 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Dapefy 10mg Tablet works:
Glycemic control is achieved with Dapefy 10mg tablets, an antidiabetic agent that facilitates the urinary excretion of surplus glucose.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Dapefy 10mg Tablets should not be taken together.
PregnancyCONSULT YOUR DOCTOR
Using Dapefy 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding mothers should likely avoid Dapefy 10mg tablets. Available evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Dapefy 10mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Seek medical advice.
LiverSAFE IF PRESCRIBED
Dapefy 10mg tablets can be used safely by individuals with hepatic impairment. No alteration of the Dapefy 10mg tablet dosage is necessary.
What if you forget to take Dapefy 10mg Tablet :
For a missed Dapefy 10mg Tablet dose, take it promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapefy 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
